AU2003203980A1 - Target genes for allele-specific drugs - Google Patents

Target genes for allele-specific drugs

Info

Publication number
AU2003203980A1
AU2003203980A1 AU2003203980A AU2003203980A AU2003203980A1 AU 2003203980 A1 AU2003203980 A1 AU 2003203980A1 AU 2003203980 A AU2003203980 A AU 2003203980A AU 2003203980 A AU2003203980 A AU 2003203980A AU 2003203980 A1 AU2003203980 A1 AU 2003203980A1
Authority
AU
Australia
Prior art keywords
allele
target genes
specific drugs
drugs
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003203980A
Inventor
David Housman
Fred D Ledley
Vincent P Stanton Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Variagenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Variagenics Inc filed Critical Variagenics Inc
Publication of AU2003203980A1 publication Critical patent/AU2003203980A1/en
Abandoned legal-status Critical Current

Links

AU2003203980A 1997-03-20 2003-05-02 Target genes for allele-specific drugs Abandoned AU2003203980A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60041057 1997-03-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU67643/98A Division AU6764398A (en) 1997-03-20 1998-03-19 Target genes for allele-specific drugs

Publications (1)

Publication Number Publication Date
AU2003203980A1 true AU2003203980A1 (en) 2003-06-12

Family

ID=

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110694050B (en) * 2019-10-18 2022-07-12 江南大学附属医院（无锡市第四人民医院） Application of PMCA4 protein in preparation of medicine for treating gastric cancer
US11834697B2 (en) 2017-09-15 2023-12-05 Oxford University Innovation Limited Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11834697B2 (en) 2017-09-15 2023-12-05 Oxford University Innovation Limited Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
CN110694050B (en) * 2019-10-18 2022-07-12 江南大学附属医院（无锡市第四人民医院） Application of PMCA4 protein in preparation of medicine for treating gastric cancer

Similar Documents

Publication Publication Date Title
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU7077098A (en) Transdermal delivery system
AU4787697A (en) Therapeutic gene
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU6740298A (en) Pharmaceutical composition
AU4549699A (en) Centerfill delivery system for nutraceuticals
AU8676698A (en) Devices for providing therapeutic substances
AU5387898A (en) Pharmaceutical agents
AU8495998A (en) Improved dosage units
AU7711098A (en) Drug delivery system
AU8107998A (en) Pharmaceutical compositions
AU1409100A (en) Drugs
AU8591898A (en) Pharmaceutical compounds
AU7201998A (en) Drug delivery system
AU8636798A (en) Pharmaceutical compounds isolated from aristolochia taliscana
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU7918398A (en) Oligonucleotide derivatives
AU4330097A (en) Pharmaceutical compounds
AU9343098A (en) Pharmaceutical composition
AU6940998A (en) Phospholipid drug derivatives
AU6328498A (en) Oligonucleotides specific for the (marorab) operon
AU4169897A (en) Pharmaceutical compounds
AU6480299A (en) Pharmaceutical compounds
AU4417000A (en) Novel pharmaceutical composition suitable for gene therapy
AU2003203980A1 (en) Target genes for allele-specific drugs